- ►physiology.org A Gastaldelli, E Ferrannini, Y Miyazaki, M … - American Journal of Physiology- Endocrinology And …, 2007 - Am Physiological Soc Thiazolidinediones (TZDs) improve glycemic control and insulin sensitivity in
patients with type 2 diabetes mellitus (T2DM). There is growing evidence from in
vivo and in vitro studies that TZDs improve pancreatic -cell function. The ... Cited by 40 - Related articles - BL Direct - All 6 versions
F Marra, A Gastaldelli, G Svegliati Baroni, G … - Trends in molecular medicine, 2008 - Elsevier Non-alcoholic steatohepatitis (NASH), a cause of cirrhosis and hepatocellular
carcinoma, is characterized by fatty infiltration of the liver, inflammation,
hepatocellular damage and fibrosis. Progress has been made in understanding ... Cited by 41 - Related articles - All 5 versions
D Lann, D LeRoith - Medical Clinics of North America, 2007 - Elsevier Classically, the metabolic syndrome is characterized as group of pathologies
including visceral obesity, hypertension, dyslipidemia, and impaired glucose
tolerance. It is now realized that insulin resistance plays a principal ... Cited by 26 - Related articles - All 25 versions
- ►nursing2008.com E Mannucci, M Monami, C Lamanna, GF … - Diabetes, Obesity and Metabolism, 2008 - pt.wkhealth.com Aim: The aim of this meta-analysis of randomized clinical trials (RCT) was to
assess whether pioglitazone is also associated with increased cardiovascular
risk, as recently reported for rosiglitazone. Methods: RCT of pioglitazone ... Cited by 14 - Related articles - All 6 versions
R Basu, P Shah, A Basu, B Norby, B Dicke, … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Glucose was clamped before and after therapy at ∼5 mmol/l, insulin
raised to ∼180 pmol/l, C-peptide suppressed with somatostatin, glucagon
replaced at ∼75 pg/ml, and glycerol maintained at ∼200 mmol/l to ensure ... Cited by 10 - Related articles - BL Direct - All 8 versions
MG Andreassi, A Gastaldelli, A Clerico, PA … - Current pharmaceutical design, 2009 - ingentaconnect.com Abstract: Imaging and laboratory biomarkers are an essential support to modern
practice of medicine, allowing a better identification, severity titration,
staging and follow-up of atherosclerosis and heart failure disease. This ... Cited by 4 - Related articles - All 3 versions
SL Norris, S Carson, C Roberts - Update, 2008 - derp.ohsu.edu The purpose of this report is to make available information regarding the
comparative effectiveness and safety profiles of different drugs within
pharmaceutical classes. Reports are not usage guidelines, nor should they ... Cited by 3 - Related articles - View as HTML - All 8 versions
C Beysen, EJ Murphy, H Nagaraja, M Decaris, T … - The Journal of Lipid Research, 2008 - ASBMB Treatment of type 2 diabetes mellitus (T2DM) patients with pioglitazone results
in a more favorable lipid profile, and perhaps more favorable cardiac outcomes,
than treatment with rosiglitazone. Pioglitazone treatment increases VLDL- ... Cited by 3 - Related articles - All 5 versions
